Developing and Diffusing New Technologies: Strategies for Legitimization

This article investigates legitimization processes and organizations' strategies for developing and diffusing new technologies. Drawing on cases in agricultural transgenic technology and genomics in forestry, the authors provide a framework to help managers develop strategies for more efficient technology development and diffusion. Strategies that fail to consider legitimization processes, especially in controversial social environments and/or varying institutional settings, could result in costly delays or promising technology left sitting on the shelf. Technology developers need to identify key technological, commercial, organizational, and societal uncertainties during the early phases of the technology's development, allowing them to shape the technology for more efficient diffusion.

[1]  T. Pinch,et al.  The Social Construction of Facts and Artefacts: or How the Sociology of Science and the Sociology of Technology might Benefit Each Other , 1984 .

[2]  K. Eisenhardt.  Building theories from case study research , 1989, STUDI ORGANIZZATIVI.

[3]  Stephen Tallman.  Managing across Borders: The Transnational Solution , 1990 .

[4]  D. North.  Institutions, institutional change and economic performance: Cambridge university press. , 1990 .

[5]  Steven C. Wheelwright,et al.  Managing New Product and Process Development: Text and Cases , 1992 .

[6]  R. Rothwell.  Successful industrial innovation: critical factors for the 1990s , 1992 .

[7]  L. Winner.  Upon Opening the Black Box and Finding It Empty: Social Constructivism and the Philosophy of Technology , 1993 .

[8]  Howard E. Aldrich,et al.  Fools Rush in? The Institutional Context of Industry Creation , 1994 .

[9]  Jeremy Hall,et al.  Biotechnology: the ultimate cleaner production technology for agriculture? , 1998 .

[10]  T. Kostova.  Transnational Transfer of Strategic Organizational Practices: A Contextual Perspective , 1999 .

[11]  Joyce Tait,et al.  More Faust than Frankenstein: the European debate about the precautionary principle and risk regulation for genetically modified crops , 2001 .

[12]  Public sector science and "the strategy of the commons" , 2001, PICMET '01. Portland International Conference on Management of Engineering and Technology. Proceedings Vol.1: Book of Summaries (IEEE Cat. No.01CH37199).

[13]  Fangbin Qiao,et al.  Transgenic Varieties and Productivity of Smallholder Cotton Farmers in China , 2002 .

[14]  H. James.  On Finding Solutions to Ethical Problems in Agriculture , 2002 .

[15]  Govindan Parayil,et al.  Mapping technological trajectories of the Green Revolution and the Gene Revolution from modernization to globalization , 2003 .

[16]  David Wield,et al.  Understanding company R&D strategies in agro-biotechnology: trajectories and blind spots , 2004 .

[17]  Harrie Vredenburg,et al.  Managing stakeholder ambiguity , 2005 .

[18]  R. Nwabueze.  What can genomics and health biotechnology do for developing countries , 2005 .

[19]  Deli Yang,et al.  Culture matters to multinationals’ intellectual property businesses , 2005 .

[20]  Jeremy Hall,et al.  Disruptive Technologies, Stakeholders and the Innovation Value-Added Chain: A Framework for Evaluating Radical Technology Development , 2005 .

[21]  Petr Hanel,et al.  Intellectual property rights business management practices: A survey of the literature , 2006 .

[22]  Stelvia Matos,et al.  Indicators and outcomes of Canadian university research: Proxies becoming goals? , 2006 .

[23]  S. Berg.  Snowball Sampling—I , 2006 .

[24]  Ronald J. Herring,et al.  Stealth seeds: Bioproperty, biosafety, biopolitics , 2007 .

[25]  Ulrich Lichtenthaler,et al.  The Drivers of Technology Licensing: An Industry Comparison , 2007 .

[26]  Jeremy Hall,et al.  Social Exclusion and Transgenic Technology: The Case of Brazilian Agriculture , 2007 .

[27]  Alexander J. Stein,et al.  Genetic Engineering for the Poor: Golden Rice and Public Health in India , 2008 .

[28]  Ammon Salter,et al.  Does IP strategy have to cripple open innovation , 2009 .

[29]  Markus Reitzig,et al.  Value Appropriation as an Organizational Capability: The Case of Ip Protection Through Patents , 2009 .

[30]  Myles T. Collins,et al.  Suppose the USA had REACH: ramifications for formaldehyde , 2010 .

[31]  David J. Spielman,et al.  Private‐sector investment in R&D: a review of policy options to promote its growth in developing‐country agriculture , 2010 .

[32]  Ingo Potrykus,et al.  Lessons from the 'Humanitarian Golden Rice' project: regulation prevents development of public good genetically engineered crop products. , 2010, New biotechnology.

[33]  S. Sterckx.  Is the Non-Patentability of “Essentially Biological Processes” Under Threat? , 2010 .

[34]  E. Roberts,et al.  Entering New Businesses: Selecting the Strategies for Success , 2011 .

[35]  David J. Teece,et al.  Innovation in Multi-Invention Contexts: Mapping Solutions to Technological and Intellectual Property Complexity , 2011 .

[36]  K. Sauvant.  Overcoming Liability for Foreignness , 2011 .

[37]  Dane Scott.  The Technological Fix Criticisms and the Agricultural Biotechnology Debate , 2011 .

[38]  Dries Faems,et al.  Building Appropriation Advantage: An Introduction to the Special Issue on Intellectual Property Management , 2013 .

[39]  M. Kumari,et al.  GM foods - a controversy between tradition and modernity , 2013 .

[40]  D. Bernardini-Zambrini,et al.  [The next society]. , 2013, Semergen.